Antifibrotic Effects of Antioxidant N-Acetylcysteine in a Mouse Model of Human Hypertrophic Cardiomyopathy Mutation
- 26 January 2006
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (4) , 827-834
- https://doi.org/10.1016/j.jacc.2005.10.041
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human Hypertrophic CardiomyopathyCirculation Research, 2005
- The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout miceKidney International, 2005
- Glutathione regulates transforming growth factor-β-stimulated collagen production in fibroblastsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 2003
- Antioxidant, N-acetyl-?-cysteine inhibits the expression of the collagen α2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-βHepatology Research, 2002
- Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathyClinical Cardiology, 2001
- Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic CardiomyopathyNew England Journal of Medicine, 2000
- Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathyJournal of Clinical Investigation, 1999
- Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice.Journal of Clinical Investigation, 1998
- A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1998